Currently, the most important risk factor for hepatitis C virus (HCV) infection in Europe is
intravenous drug use. To establish a better insight into the epidemiology of hepatitis C …

Despite the high prevalence of hepatitis C virus (HCV) infection among drug users enrolled
in methadone maintenance treatment programs, few drug users are being treated with …

BACKGROUND: Illicit drug users account for the majority of cases of HCV infection in the
developed world, but few have received treatment. METHODS: We evaluated barriers to …

Aims The three primary objectives of this study were (1) to document the prevalence of the
hepatitis C virus (HCV) and awareness of one's status in a sample of street‐recruited …

Despite recent improvements in outcomes of treatment for infection with hepatitis C virus
(HCV), very few current injection drug users (IDUs) have access to treatment programs. We …

We surveyed 306 former injection drug users receiving methadone maintenance treatment
in 1997–1998 in Providence, RI regarding,(1) knowledge of hepatitis C transmission;(2) the …

Objective. This study was conducted to assess the accuracy of self-reported hepatitis C virus
(HCV) antibody (anti-HCV) serostatus in injection drug users (IDUs), and examine whether …

The National Treatment Outcome Research Study (NTORS) is a longitudinal, multisite,
prospective cohort study that assesses changes in illicit drug use and other problems after …

Aim Better sterile syringe access should be associated with a lower likelihood of syringe re‐
use and receptive syringe sharing, although few empirical studies have examined gradients …

Introduction: We examined correlates of HBV infection and vaccination and the missed
vaccination opportunities among young injection drug users (IDUs) and non-injection drug …